Delpha Construction Co.,Ltd. (TPE:2530)

Orchard Therapeutics Revenue

Delpha Construction had revenue of 161.57M TWD in the quarter ending March 31, 2025, a decrease of -78.74%. This brings the company's revenue in the last twelve months to 5.50B, up 103.03% year-over-year. In the year 2024, Delpha Construction had annual revenue of 6.10B with 212.34% growth.

• Revenue (ttm): 5.50B
• Revenue Growth: +103.03%
• P/S Ratio: 4.36
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 23.94B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	6.10B	4.14B	212.34%
Dec 31, 2023	1.95B	-42.83M	-2.15%
Dec 31, 2022	1.99B	1.99B	22,775.44%
Dec 31, 2021	8.72M	-78.66M	-90.02%
Dec 31, 2020	87.38M	77.21M	759.16%